Skip to content

Evaluation of Muscle Electrical Stimulation and Creatine Supplementation in Renal Hemodialysis Patients

Evaluation of Eletro Neuromuscular Stimulation and Supplementation of Creatine in Renal hemodialysis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-98wzgn
Enrollment
Unknown
Registered
2018-01-25
Start date
2016-09-14
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dialysis renal, sarcopenia, inflammation,

Interventions

Four randomized groups: Placebo Group (GP): Composed of 14 subjects who will receive placebo (maltodextrin) for one month
Creatine + Electro stimulus group (GC + EC): Composed of 14 individuals who will receive creatine and neuromuscular electrical stimuli for one month
Electro stimulus group (GE): Composed of 14 individuals who will receive placebo (maltodextrin) and neuromuscular electrical stimuli for one month
Creatine Group (GC): Consists of 14 individuals who will receive creatine for one month. The intervention will occur within a period of one month, always during the HD sessions.
Device
Dietary supplement
E05.723.402

Sponsors

Faculdade de Nutrição da Universidade Federal de Goiás
Lead Sponsor
Faculdade de Nutrição da Universidade Federal de Goiás
Collaborator

Eligibility

Age
18 Years to 59 Years

Inclusion criteria

Inclusion criteria: Patients with a diagnosis of chronic kidney disease; undergoing hemodialysis for more than 3 months; of both sexes; and aged between 18 and 59 years

Exclusion criteria

Exclusion criteria: Patients with neurological diseases; severe cardiovascular diseases; physical impairments (amputations, deep vein thrombosis); and patients who underwent long-term and structured high-resistance training three months prior to the date of inclusion in the study.

Design outcomes

Primary

MeasureTime frame
Reduce the loss of lean mass in the period of 01 month verified by dual-energy x-ray absorptiometry from the observation of a variation of at least 5% in the pre- and post-intervention measurements

Secondary

MeasureTime frame
Secondary outcomes are not expected

Countries

Brazil

Contacts

Public ContactAna Clara Marini

Faculdade de Nutrição da Universidade Federal de Goiás

ac.marini22@gmail.com+55(62)982175651

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 23, 2026